BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

700 related articles for article (PubMed ID: 23616386)

  • 1. Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial.
    Wang DH; Chen L; Cheng L; Li KN; Yuan H; Lu JH; Li H
    Laryngoscope; 2013 Jun; 123(6):1334-40. PubMed ID: 23616386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy.
    Baron-Bodo V; Batard T; Nguyen H; Fréreux M; Horiot S; Harwanegg C; Bergmann KC; de Beaumont O; Moingeon P
    Clin Exp Allergy; 2012 Oct; 42(10):1510-8. PubMed ID: 22994348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in serum specific IgG4 and IgG4/ IgE ratio in mite-sensitized Taiwanese children with allergic rhinitis receiving short-term sublingual-swallow immunotherapy: a multicenter, randomized, placebo-controlled trial.
    Tseng SH; Fu LS; Nong BR; Weng JD; Shyur SD
    Asian Pac J Allergy Immunol; 2008; 26(2-3):105-12. PubMed ID: 19054928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.
    Lue KH; Lin YH; Sun HL; Lu KH; Hsieh JC; Chou MC
    Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and safety of sublingual immunotherapy with house dust mite extract in poly allergen sensitized children with allergic rhinitis].
    Zhou L; Wang J; Chen Y; Luo R; Tao J; Nie M; Liu B; Li Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 26(20):913-6. PubMed ID: 23272490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan.
    Niu CK; Chen WY; Huang JL; Lue KH; Wang JY
    Respir Med; 2006 Aug; 100(8):1374-83. PubMed ID: 16403616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depigmented and polymerised house dust mite allergoid: allergen content, induction of IgG4 and clinical response.
    Gallego MT; Iraola V; Himly M; Robinson DS; Badiola C; García-Robaina JC; Briza P; Carnés J
    Int Arch Allergy Immunol; 2010; 153(1):61-9. PubMed ID: 20357486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study.
    Yukselen A; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB
    Int Arch Allergy Immunol; 2012; 157(3):288-98. PubMed ID: 22041501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: a double-blind, placebo-controlled study.
    Guez S; Vatrinet C; Fadel R; André C
    Allergy; 2000 Apr; 55(4):369-75. PubMed ID: 10782522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in inflammatory and clinical parameters and in bronchial hyperreactivity asthmatic children sensitized to house dust mites following sublingual immunotherapy.
    Silvestri M; Spallarossa D; Battistini E; Sabatini F; Pecora S; Parmiani S; Rossi GA
    J Investig Allergol Clin Immunol; 2002; 12(1):52-9. PubMed ID: 12109533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized double-blind placebo-controlled trial of sublingual immunotherapy in children with house dust mite allergy in primary care: study design and recruitment.
    de Bot CM; Moed H; Berger MY; Röder E; de Groot H; de Jongste JC; van Wijk RG; van der Wouden JC
    BMC Fam Pract; 2008 Oct; 9():59. PubMed ID: 18937864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of cluster and conventional immunotherapy schedules with dermatophagoides pteronyssinus in the treatment of persistent allergic rhinitis.
    Zhang L; Wang C; Han D; Wang X; Zhao Y; Liu J
    Int Arch Allergy Immunol; 2009; 148(2):161-9. PubMed ID: 18802361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and immunologic effects of sublingual immunotherapy on patients with allergic rhinitis to house-dust mites: 1-year follow-up results.
    Kim ST; Han DH; Moon IJ; Lee CH; Min YG; Rhee CS
    Am J Rhinol Allergy; 2010; 24(4):271-5. PubMed ID: 20819465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. House dust mite sublingual immunotherapy: results of a US trial.
    Bush RK; Swenson C; Fahlberg B; Evans MD; Esch R; Morris M; Busse WW
    J Allergy Clin Immunol; 2011 Apr; 127(4):974-81.e1-7. PubMed ID: 21333346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study.
    García-Robaina JC; Sánchez I; de la Torre F; Fernández-Caldas E; Casanovas M
    J Allergy Clin Immunol; 2006 Nov; 118(5):1026-32. PubMed ID: 17088125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of sublingual immunotherapy with house dust mite extract in polyallergen sensitized patients with allergic rhinitis.
    Lee JE; Choi YS; Kim MS; Han DH; Rhee CS; Lee CH; Kim DY
    Ann Allergy Asthma Immunol; 2011 Jul; 107(1):79-84. PubMed ID: 21704889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy.
    Tonnel AB; Scherpereel A; Douay B; Mellin B; Leprince D; Goldstein N; Delecluse P; Andre C
    Allergy; 2004 May; 59(5):491-7. PubMed ID: 15080829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of sublingual immunotherapy with dermatophagoides farinae drops in patients with allergic rhinitis].
    Li TY; Chen DH; Lin ZB; Xu R
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Oct; 46(10):859-62. PubMed ID: 22321427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.